ACM
MDCO

Ashford Capital Management’s Medicines Co MDCO Stock Holding History

Ashford Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-272,210
Closed -$10.1M – 107
2017
Q3 		$10.1M Sell
272,210
-11,863
-4% -$437K 1.62% 22
2017
Q2 		$10.8M Sell
284,073
-9,371
-3% -$417K 1.89% 19
2017
Q1 		$14.3M Sell
293,444
-80,670
-22% -$3.68M 2.76% 11
2016
Q4 		$12.7M Buy
374,114
+457
+0.1% +$16.2K 2.55% 11
2016
Q3 		$14.1M Buy
373,657
+5,265
+1% +$198K 2.9% 9
2016
Q2 		$12.4M Sell
368,392
-24,433
-6% -$861K 2.77% 10
2016
Q1 		$12.5M Sell
392,825
-4,590
-1% -$150K 2.96% 6
2015
Q4 		$14.8M Buy
397,415
+4,271
+1% +$161K 3.49% 7
2015
Q3 		$14.9M Buy
393,144
+40,244
+11% +$1.41M 3.5% 5
2015
Q2 		$10.1M Sell
352,900
-17,050
-5% -$475K 2.23% 11
2015
Q1 		$10.4M Buy
369,950
+11,750
+3% +$330K 2.11% 9
2014
Q4 		$9.91M Buy
358,200
+81,615
+30% +$2.02M 1.97% 12
2014
Q3 		$6.17M Buy
276,585
+8,300
+3% +$211K 1.33% 27
2014
Q2 		$7.8M Buy
268,285
+107,610
+67% +$2.87M 1.56% 18
2014
Q1 		$4.57M Buy
160,675
+98,844
+160% +$3.27M 0.88% 44
2013
Q4 		$2.39M Buy
+61,831
New +$2.21M 0.45% 65

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ashford Capital Management's MDCO Position: Q4 2017 in Review

Ashford Capital Management sold out of Medicines Co (MDCO) in Q4 2017, closing a stake of 272,210 shares — an estimated $10.1M sold.

Ashford Capital Management first reported a position in MDCO in Q4 2013 and held it in 16 quarters. The position peaked at $14.9M in Q3 2015. 202 funds tracked by Wall St. Rank hold MDCO as of Q4 2017.

  • Ashford Capital Management reported no remaining Medicines Co position as of Q4 2017 after selling out during the quarter.
  • Ashford Capital Management sold 272,210 Medicines Co shares in Q4 2017, an estimated $10.1M.
  • Ashford Capital Management first reported a position in Medicines Co in Q4 2013 and held it in 16 quarters.
  • Ashford Capital Management's Medicines Co position peaked at $14.9M in Q3 2015.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q4 2017.

Based on Ashford Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.